RecruitingNCT06408701

Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With Ocular Malformations


Sponsor

University Hospital, Toulouse

Enrollment

20 participants

Start Date

Nov 5, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Ocular morphogenesis is a complex process starting as early as the 4th week of embryonic life, involving interactions between varioustissues of different origin and conserved genes. Anomalies in ocular development , often of genetic origin, pose diagnostic and therapeutic challenges. Animal models are limited, so human-induced pluripotent stem cell (hiPSC)-derived optic vesicle containing brain organoids (OVBOs) offer a promising alternative. These pathological OVBOs, created from patients' cells with ocular malformations, allow for the study of underlying molecular mechanisms and testing of therapies.


Eligibility

Min Age: 6 Years

Inclusion Criteria3

  • Affiliated with a social security scheme.
  • Patients with ocular malformations.
  • Signed informed consent obtained from the patient and/or their legal representatives.

Exclusion Criteria3

  • Inability to understand the nature and objectives of the study and/or difficulties in communicating with the investigator.
  • Deprivation of liberty by judicial or administrative decision.
  • Any other pathological or psychological condition deemed incompatible by the investigator for the proper conduct of the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALBlood sampling

Blood will be taken in larger quantity


Locations(2)

CHU de Clermont-Ferrand - Hôpital d'Estaing

Clermont-Ferrand, France

Purpan University Hospital

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06408701